
    
      This study is a double-blind, placebo-controlled, randomized trial designed to assess the
      efficacy and safety of gefapixant in female participants with moderate to severe pain
      associated with IC/BPS. The study will consist of 4 phases: Screening, Baseline, Treatment,
      and Follow-up.
    
  